|
||||||||||
|
On Innovation and Commercialization
April 2009 v.1, n.6
|
||||||||||
|
OPINION There is little that we can say about the current economic environment about which pundits have not already pontificated ad nauseam (causing most of us nausea in the bargain). As is almost always the case in our over-analyzed, overwrought society, each hysterical pronouncement builds off another, which then succeeds in begetting yet another gem of diminished wisdom but overreaching cleverness. There is just no point in trying to "penetrate the arcana of the modern Babylon," as Dickens wrote so memorably in David Copperfield. Instead, it is time, again, to count our blessings and consider the virtues and values of entrepreneurship. Read more ... Revolutionary
Water Sensors
Researchers at the University of Illinois at Urbana-Champaign have synthesized DNA to detect trace amounts of lead, mercury, arsenic and other contaminants in water. The DNA sensors can be produced in the form of sophisticated testing instruments suitable for metropolitan water districts or in the form of strips - like a home pregnancy test - for households and other direct-source water users. Read more ...
Larta Institute
has been selected by Paris-based OECD (the Organization for Economic
Co-operation and Development) to conduct a study project on SME
Innovation and Intellectual Asset Management. The project, including
templates for case studies in creative industries and select manufacturing
and service sectors, will cover up to six OECD countries. The project,
under the direction of the Deputy Director of the Centre for Entrepreneurship,
SMEs and Local Development (CFE) and the Working Party on SMEs
and Entrepreneurship (WPSMEE), will commence in late April, 2009. Stay
tuned for more details!
This session will
look at the few key practices a company should adopt in commercializing
their product or service, especially when things seem to be "locked
in place" because of sub-optimal economic conditions. Smaller companies
have had to deal with the difficulties of navigating new or established
markets in any case; the current economic climate provides them with
opportunities that may not have been available before. The session will
discuss the National Institutes of Health's national Commercialization
Assistance Program, designed and managed by Larta Institute for the
NIH, to demonstrate how these approaches are being put into practice,
and present some results from the program showing the importance of
new perspectives for emerging and established companies alike. Webinar
is hosted by Q1 Productions - Register Experts and Evangelists at the 2009 Life Sciences Venture Forum The 2009 Life Sciences Venture Forum, the premier event where industry leaders and emerging companies have converged for the past 15 years. This year - June 25, 2009 at the Fairmont Hotel, San Jose, CA. This is the one event that features both the engaged experts and the earnest evangelists. Go one-on-one with industry thought leaders as they discuss challenges and opportunities in funding for enterprise development in the life sciences following the stimulus package, the $10B allotment to NIH. Join Pfizer, Thallo Biosciences and Stellartech Research in discussion about novel product development approaches involving increased outsourcing to smaller companies, among others. Find out how the worlds of bio and cleantech are becoming more engaged with each other. It is not only the thought that counts, however. And this event is not just for the talking heads. It allows you also the opportunity to hear from and meet with the people that make the innovation happen - seed and early-stage companies funded by National Institutes of Health, researchers from top universities across the United States and entrepreneurs from Larta Institute's own network of imaginative innovators. Few presenting spots
available. To apply go to http://www.theventureforum.com/Apply.aspx LartaVOX readers receive a 30% discount. Use coupon code VOXVF09 The 2009 Ag Innovation Showcase will feature companies and their innovative approaches to advancing productivity and sustainability in agriculture. Leading- edge technologies will be represented from the sectors of ag-biotech, food and nutrition, alternative energy, informatics, animal health, and sustainable materials. To promote the advancement of these technologies and to stimulate dialogue between stakeholders, The Ag Innovation Showcase will bring together entrepreneurs, investors, corporate leaders, and public officials a for a two day conference that will:
For more information
or to register to attend, visit our website at www.agshowcase.com BusinessWeek columnist Karen E. Klein interviewed Larta's CEO Rohit Shukla for her article Swapping Equity for Services. Shukla maintains that "two factors will make this more prevalent: One, the number of unemployed service providers who are unemployable in this economy; and two, the fact that they are floating around, looking for something to sink their teeth into rather than do nothing."Read more Larraine D. Segil, former Larta board member and current industry advisor, has been appointed by TDR, the Special Programme for Research and Training, to be a member of the Strategic Alliances Advisory Group. The programme is co-sponsored by UNICEF, UNDP, the World Bank and the World Health Organization and is set up to help foster an effective global research effort on infectious diseases of poverty.
2008-2009 NIH Commercialization Assistance Program (CAP) participant, ECI Biotech (Worcester, MA). is a diagnostics company with extensive intellectual property in simple, inexpensive, and rapid diagnostics, called ExpressDetect®. ExpressDetect® sensors can be specifically designed to address diverse applications in professional as well as consumer markets such as wound care, women's health, and oral care. ExpressDetect sensors are safe and simple enough to be incorporated into any medical device, such as a band aid that would change color if the wound is infected. ExpressDetect can also be incorporated into a rapid point of care cassette format that is ideal for wound clinics and outpatient settings. 2008-2009 NIH
Commercialization Assistance Program (CAP) participant, Fluential
(Sunnyvale, CA), provides fast, fluent automated speech translation
for healthcare providers. Using funding from DARPA, NIST, NIH, and other
government agencies; the company has created one of the most advanced
platforms for speech translation technology in the world. Its products
enable people who speak different languages to communicate face-to-face
in real time. NIH ANNOUNCES GRANT OPPORTUNITIES
For information please visit http://grants.nih.gov/grants/funding/challenge_award/ and http://grants.nih.gov/recovery/
Over September 9-10, 2009, clean technology sector leadersrepresenting trillions of dollars in capitalwill assemble in Boston for Cleantech Forum XXIII at the Boston Convention & Exhibition Center to drive demand and open clean technology markets. Entrepreneurs, CEOs, scientists, policy-makers and an assembly of global forerunners of the clean technology sector will meet to discuss, debate and forge solutions to the current global economic challenges as they relate to cleantech. Register for the annual East Coast cleantech gathering at www.cleantech.com/bostonforum For more information, call 810 224 4310 or email info@cleantech.com
Early Stage Financing - Capital Sources Include:
Submit your deal or register to attend at www.GCC2000.org. Use coupon code LARTA for a $20 discount! Expires April 10, 2009.
In a volatile economy, it is more important than ever to understand core business decisions in BioPharma. The BioExec Institute focuses on management decision-making in a complex R&D, operational, regulatory and market environment. Join other managers at BioExec Institute 2009 to debate and discuss the business, issues and trends facing BioPharma. This Institute is the only Executive Education series specifically designed to discuss business strategies with key leaders who have provided unique value to the industry. Co-produced by UC Berkeley, Deloitte and Prescience Intl, the BioExec Institute brings together director and VP-level management for this six-day interactive program [3 modules of 2 days each]. For more information or to register, visit http://www.prescienceintl.com/bioexec.html.
Venture Summit East, copresented by JPMorgan, is a two-day gathering that highlights the significant economic, political and technology trends impacting the global growth investor. Now more than ever, staying abreast of market conditions and innovations is crucial to financial success. Venture Summit East features the most influential institutional investors, venture capitalists, corporate buyers, investment bankers and research analysts in the Eastern US in keynote presentations and panel debates. Venture Summit East will also debut AlwaysOn's Northeast 100 Companies list, and play host to CEO Showcases from qualified companies seeking later-stage capital or potential acquirers. For more information please visit alwayson.goingon.com
GoingGreen is where
cutting-edge greentech CEOs meet the movers and shakers from the biggest
industries on earth. Green technology innovators are transforming trillion
dollar industries - and the solutions they are delivering not only promise
to clean up pollution and restore ecosystems, but also to bring abundance
and prosperity to everyone on earth. In fundamental areas, water, energy
and land, resource abundance is just around the corner, through the
power of technology and free markets. This two-and-a-half-day executive
event features CEO presentations and high-level debates on the most
promising emerging green technologies and new entrepreneurial opportunities.
At GoingGreen, our editors will also honor the GoingGreen 100 Top Private
Companies. Fifty of the top CEOs from the GoingGreen 100 will pitch
their market strategies to a panel of industry experts in our "CEO
Showcase." For more information please visit alwayson.goingon.com
|
|||||||||